EUVIMEDEUVIMED entdecken
Crossref

Cost Minimization Analysis of Empiric Antibiotic Used by Sepsis Patient Respiratory Infection Source

Okky S. Purwanti, Rizky Abdulah, Ivan S. Pradipta, Cherry Rahayu2

Indonesian Journal of Clinical Pharmacy · 2014

DOI: 10.15416/ijcp.2014.3.1.10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indonesian Journal of Clinical Pharmacy, 2014. Verfasst von Okky S. Purwanti und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Terapi antibiotik empirik merupakan salah satu penunjang keberhasilan dalam pengobatan sepsis. Penelitian ini bertujuan untuk mengetahui kombinasi antibiotik empirik yang paling efisien secara biaya ( cost minimization ) di antara sefotaksim-eritromisin dan sefotaksim-metronidazol yang digunakan pada sepsis sumber infeksi pernapasan yang dirawat di salah satu rumah sakit di Kota Bandung. Penelitian ini merupakan studi observasional dengan pengumpulan data secara retrospektif tahun 2010–2012. Data diambil dari rekam medis pasien rawat inap sepsis sumber infeksi pernapasan yang mendapat terapi antibiotik empirik sefotaksim-metronidazol atau sefotaksim-eritromisin dan daftar biaya dari bagian akuntansi rumah sakit. Biaya dihitung dari mulai pasien masuk rumah sakit dengan diagnosis sepsis sumber infeksi pernapasan sampai pasien sembuh dari sepsis. Antibiotik efotaksimmetronidazol dan sefotaksim-eritromisin diasumsikan memiliki efek yang sebanding. Pasien dengan terapi empirik sefotaksim-metronidazol memiliki waktu tinggal di rumah sakit lebih lama (25 ibanding 11) dan memiliki total biaya rata-rata terapi lebih murah (Rp16.641.112,04 dibandingkan dengan Rp21.641.678,02) daripada pasien dengan terapi empirik sefotaksim-eritromisin. Hasil ini menunjukkan bahwa kombinasi antibiotik sefotaksim-metronidazol lebih efisien secara biaya dibandingkan dengan kombinasi sefotaksim-eritromisin. Kata kunci: Antibiotik empirik, cost minimization, eritromisin, metronidazol, sefotaksim, sepsis Cost Minimization Analysis of Empiric Antibiotic Used by Sepsis Patient Respiratory Infection Source Empirical antibiotics plays an important role in the therapy of sepsis. The aims of this study was to estimate and compare the cost of treating inpatient sepsis with respiratory infection, with cefotaximemetronidazole or cefotaxime-erythromycin antibiotics. Observational study of cost minimization analysis was conducted by retrospective data from 2010 until 2012. Data were collected from medical records of inpatients sepsis with respiratory infection and received empirical therapy cefotaximemetronidazole or cefotaxime-erythromycin and treatment’s pricelist from department of accounting. Direct medical cost was calculated from empirical antibiotic costs, costs of medical treatment, medical expenses, hospitalization costs, and administrative costs. The study considered the cost from preadmission because sepsis until the patient was fully recovered of sepsis. Cefotaxime-metronidazole and cefotaxime-erythromycin are assumed to have equivalent efficacy. Patients with empirical cefotaxime -metronidazole were found have longer length of stay (25 versus 11) and average total cost of treatment was cheaper (16.641.112,04 IDR versus 21.641.678,02 IDR). The findings demonstrate that combination of empirical antibiotic of cefotaxime–metronidazole is more efficient than cefotaxime-erythromycin. Key words: Cost minimizing, cefotaxime, empirical antibiotic erythromycin, metronidazole, sepsis

Zitieren

APA

Purwanti, O. S., Abdulah, R., Pradipta, I. S., & Rahayu2, C. (2014). Cost Minimization Analysis of Empiric Antibiotic Used by Sepsis Patient Respiratory Infection Source. Indonesian Journal of Clinical Pharmacy. https://doi.org/10.15416/ijcp.2014.3.1.10

Vancouver

Purwanti OS, Abdulah R, Pradipta IS, Rahayu2 C. Cost Minimization Analysis of Empiric Antibiotic Used by Sepsis Patient Respiratory Infection Source. Indonesian Journal of Clinical Pharmacy. 2014. doi:10.15416/ijcp.2014.3.1.10

BibTeX
@article{Purwanti2014,
  author = {Purwanti, Okky S. and Abdulah, Rizky and Pradipta, Ivan S. and Rahayu2, Cherry},
  title = {Cost Minimization Analysis of Empiric Antibiotic Used by Sepsis Patient Respiratory Infection Source},
  journal = {Indonesian Journal of Clinical Pharmacy},
  year = {2014},
  doi = {10.15416/ijcp.2014.3.1.10}
}
Kostenlos starten →